Emcure Pharmaceuticals Ltd IPO

Well-placed to leverage leading position in the domestic market.

Demonstrated capabilities of building brands.

Large, diversified and fast-growing product portfolio in international markets.

Strong R&D capabilities driving differentiated portfolio of products.

Extensive and diversified manufacturing capacity.

Highly qualified, experienced and entrepreneurial management team and its Board.

Any manufacturing or quality control problems may damage its reputation, subject it to regulatory action, and expose it to litigation or other liabilities, which could adversely affect the company reputation, business, financial condition and results of operations.

Its failures to comply with applicable quality standards may result in product liability claims, which could adversely affect its business, financial condition, cash flows and results of operations.

Its manufacturing and research and development operations are subject to operational risks. Any slowdown or shutdown in its manufacturing or research and development operations could adversely affect its business, financial condition and results of operations.

The company is subject to extensive government regulations and if its fail to obtain, maintain or renew the company statutory and regulatory licenses, permits and approvals required to operate its business, the companys business, financial condition, results of operations and cash flows may be adversely affected.

Any disruptions to the supply, or increases in the pricing, of the raw materials and finished products that its outsource, may adversely affect the supply and pricing of its products and, in turn, adversely affect the companys business, cash flows, financial condition and results of operations.

The company has significant working capital requirements. If its experience insufficient cash flows to fund the company working capital requirements or if the company is not able to provide collateral to obtain letters of credit and bank guarantees in sufficient quantities, there may be an adverse effect on its business, financial condition, results of operations and cash flows.

Its inability to meet the company obligations, including financial and other covenants under its debt financing arrangements could adversely affect its business, financial condition, results of operations and cash flows.

Its inability to accurately forecast demand for the company products and manage our inventory may have an adverse effect on its business, financial condition, results of operations and cash flows.

The company is dependent on third parties for the distribution and marketing of its products. If the company does not maintain and increase the number of its arrangements for the marketing and distribution of its products, the company business, financial condition and results of operations could be adversely affected.

The determination of the Price Band is based on various factors and assumptions and the Offer Price of the Equity Shares, market capitalization and price to earnings ratio based on the Offer Price of the Equity Shares, may not be indicative of the market price of the Company on listing or thereafter.